WeVote
Log In

Bill

Bill

A 1843

Requires pharmacies to sell hypodermic syringes and needles to any customer over the age of 18 and post sign concerning consumer right to purchase clean syringes and needles.

2024-2025 Regular Session Introduced by Carol Murphy and 1 co-sponsor

New Jersey pharmacy sales mandate requires drugstores to sell syringes/needles to adults 18+ and post consumer rights signage promoting clean needle access.

Introduced in the Assembly, Referred to Assembly Health Committee
#consumerrig #pharmaceutic
0
WeVote Research Nonpartisan
Bill Summary · A 1843

Legislative bill overview

Bill A 1843 requires pharmacies in New Jersey to sell hypodermic syringes and needles to any customer 18 years or older without restriction, and mandates that pharmacies post signage informing customers of their right to purchase clean syringes and needles. The bill removes age verification barriers and creates an affirmative public notice requirement at pharmacy locations.

Why is this important

This legislation addresses public health infrastructure related to harm reduction strategies. Clean syringe access programs are associated with reduced transmission of bloodborne diseases like HIV and Hepatitis C among people who use drugs, while also potentially reducing needle-sharing behaviors. The policy represents a significant shift in pharmacy access standards that could affect disease prevention outcomes in communities with high injection drug use rates.

Potential points of contention

  • Drug policy disagreement: Opponents may argue the bill facilitates drug use by removing barriers to obtaining injection equipment, while proponents counter it's a public health measure that doesn't enable drug use but reduces harms among people already using drugs
  • Pharmacy burden and liability concerns: Pharmacy owners and associations might object to mandatory participation and posted signage, citing operational concerns, liability questions, or philosophical objections to facilitating drug use
  • Implementation specifics unclear: The bill doesn't address whether pharmacies can decline sales for other reasons, how "any customer" is verified, or whether pharmacists' personal objections are accommodated

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.